What chemo drug is given with Herceptin?
Herceptin is approved, in combination with chemotherapy (cisplatin and either capecitabine or 5-fluorouracil), for the treatment of HER2-positive metastatic cancer of the stomach or gastroesophageal junction (where the esophagus meets the stomach) in patients who have not received prior treatment for their metastatic …
How effective is Abraxane for breast cancer?
Following treatment with Abraxane, nearly half (48%) of all patients achieved a complete or partial disappearance of their cancer. For the group of patients that were treated with Abraxane as initial therapy for their metastatic breast cancer, 64% achieved a complete or partial disappearance of their cancer.
Is Herceptin better than chemotherapy?
Patients treated with Herceptin had a 33% reduced risk of death compared to those treated with chemotherapy only. Rates of severe cardiotoxicity occurred in approximately 4% of patients treated with Herceptin in the B-31 trial and approximately 3% of patients treated with Herceptin on the N9831 trial.
What is the success rate of Abraxane?
RESULTS: The treatment completion rate of the 4 cycles was 90.9%. The objective response rate was 13.6% and the disease control rate was 63.6%. The median progression-free survival was 7.2 months.
How many cycles of Abraxane can you have?
Abraxane is usually given once every three weeks (i.e. on day 1 of a 21-day cycle). Each infusion is called one ‘cycle’ of chemotherapy. Your doctor will decide how many of these cycles you will need. Abraxane is given every week (i.e. on days 1, 8 and 15 of each 21- day cycle).
Is Herceptin considered a chemotherapy drug?
Herceptin is an intravenous drug that is part of a chemotherapy regimen that is used to prevent recurrence of breast cancer, and for the treatment breast cancer that has spread beyond the breast (metastasized). It belongs to a class of drugs called monoclonal antibodies.